Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2021
Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II studyNingjing Lin, Mingzhi Zhang, Hai Bai, et al.
Acta Haematologica|October 21, 2025
Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional SurveyJunling Zhuang, Hongxia Shi, Xiaoli Liu, et al.
Leukemia & Lymphoma|June 8, 2021
Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasmsDayu Shi, Hongxia Shi, Xiaoli Liu, et al.
Acta Haematologica|February 22, 2023
Patient-Reported Outcomes in Young Adults with Myeloproliferative NeoplasmsMei Bao, Mengyu Zhang, Hongxia Shi, et al.
The New England Journal of Medicine|June 4, 2024
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple MyelomaThierry Facon, Meletios-Athanasios Dimopoulos, Xavier P Leleu, et al.
The Lancet. Haematology|June 17, 2024
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 studyYu Hu, Xiaofan Liu, Hu Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2024
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective StudyXiaoshuai Zhang, Na Xu, Yunfan Yang, et al.
Blood|July 24, 2024
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapyXiaoshuai Zhang, Bingcheng Liu, Jian Huang, et al.
Pageof 7